ADGM — Adagio Medical Holdings Share News
0.000.00%
Last trade - 00:00Brief: Adagio Medical Holdings, Receives FDA Breakthrough Device Designation For The Vclastm Cryoablation System
Brief: Adagio Medical Appoints Deborah Kaster As Chief Business Officer
Brief: Adagio Medical provides clinical, business updates
Brief: Adagio Medical Holdings Says On January 30, Terminated Facilities And Services Agreement With Fjord Ventures
Brief: Adagio Medical Holdings Enters Limited Waiver And Amendment Agreement
Brief: Adagio Medical Holdings Co Will Not Be In Compliance With Audit Committee Requirement Under Nasdaq Listing Rule 5605(C)(2)(A) As Of January 1, 2025
U.S. STOCKS ON THE MOVE-Teradyne, Keysight Technologies, Ametek
U.S. STOCKS ON THE MOVE-HeartBeam, Teradyne, Keysight Technologies
Adagio Medical Holdings down; founder, CEO Olav Bergheim steps down
Brief: Adagio Medical Announces Appointment Of Todd Usen As Chief Executive Officer And Director
Brief: Adagio Medical Provides Business Updates
Brief: Arya Sciences Acquisition Corp IV Approved One-Month Extension Of Time Period During Which It May Consummate Initial Business Combination
Brief: Adagio Medical To List On Nasdaq Through Business Combination With ARYA Sciences Acquisition Corp IV
Brief: ARYA Sciences Acquisition Corp IV- Approved Extension Of Time Period To Consummate An Initial Business Combination To Sept 2, 2023
Brief: Arya Sciences Acquisition Says Financial Statements For Affected Period, In Quarterly Reports, Should No Longer Be Relied Upon
Factbox: Most short-lived SPAC deals of 2022
U.S. STOCKS ON THE MOVE-Change Healthcare, Skillz, Nikola, Moderna
ARYA Sciences SPAC dips after ending deal with Amicus
Brief: Arya Sciences Acquisition Corp Iv And Amicus Therapeutics, Inc. Mutually Agree To Terminate Business Combination Agreement With Respect To The Acquisition Of Amicus’ Gene Therapy Business Due To Market Conditions